<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05160571</url>
  </required_header>
  <id_info>
    <org_study_id>ISI-ION-R01</org_study_id>
    <nct_id>NCT05160571</nct_id>
  </id_info>
  <brief_title>A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions</brief_title>
  <official_title>A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intuitive Surgical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a retrospective multi-center chart review of patients who underwent an&#xD;
      attempted biopsy of one or more pulmonary lesion(s) with the Ion Endoluminal System with the&#xD;
      aim of assessing the overall performance of the system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a retrospective multi-center chart review of patients who underwent an&#xD;
      attempted biopsy of one or more pulmonary lesion(s) with the Ion Endoluminal System with the&#xD;
      aim of assessing the overall performance of the system. The primary objectives of the study&#xD;
      will be performance (evaluated by diagnostic yield and sensitivity for malignancy) and safety&#xD;
      (assessed by rate of pneumothoraces and bleeding events).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>Intra-operative through the one year follow up period</time_frame>
    <description>Diagnostic yield of the sample obtained through the bronchoscopy procedure, with diagnostic yield defined as (true positives + true negatives)/(total number of lesions biopsied)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity for malignancy</measure>
    <time_frame>Intra-operative through the one year follow up period</time_frame>
    <description>Sensitivity for malignancy of the sample obtained</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pneumothorax</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Incidence of all pneumothoraces related to the Ion procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Incidence of bleeding in which an intervention was required, related to the Ion procedure. Interventions include: administration of cold saline, vasoactive substances, thrombin, or similar in response to active bleeding; use of bronchial/balloon blocker; use of bronchial artery embolization or resuscitation or ICU admission.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Intra-operative through 30 days</time_frame>
    <description>All adverse events related to the Ion procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversions</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Procedures converted to an alternative approach or terminated</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Pulmonary Nodule</condition>
  <arm_group>
    <arm_group_label>Subjects with Ion Endoluminal sampling of pulmonary nodule</arm_group_label>
    <description>Subjects in which a pulmonary lesion biopsy was attempted or performed with the Ion Endoluminal System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ion Endoluminal System</intervention_name>
    <description>Ion Endoluminal Procedure for pulmonary nodule</description>
    <arm_group_label>Subjects with Ion Endoluminal sampling of pulmonary nodule</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who underwent an Ion Endoluminal Procedure with a pulmonary nodule, 18 years or&#xD;
        older&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject was 18 years or older at the time of the procedure&#xD;
&#xD;
          -  Biopsy procedure attempted/performed using the Ion Endoluminal System&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Biopsy procedure was not attempted with the Ion Endoluminal System&#xD;
&#xD;
          -  Biopsy procedure attempted with the Ion Endoluminal System occurred less than 12&#xD;
             months prior to IRB approval&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glen Bouder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Winchester Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alison Gorski</last_name>
    <phone>(408) 523-1855</phone>
    <email>alison.gorski@intusurg.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sundeep Master</last_name>
    <phone>(408) 523-1045</phone>
    <email>sundeep.master@intusurg.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Manager</last_name>
      <phone>540-536-5980</phone>
    </contact>
    <investigator>
      <last_name>Glen Bouder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 15, 2021</study_first_submitted>
  <study_first_submitted_qc>December 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 15, 2021</last_update_submitted>
  <last_update_submitted_qc>December 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

